TSHA Institutional Ownership

TAYSHA GENE THERAPIES INC

Latest close $6.34 as of Aug 5, 2026

Schedule 13G/13D reports beneficial ownership at an observation date. “Accumulation” or “reduction” is inferred from changes in reported shares when available; it is not a list of individual trades or exact execution prices. Form 13F rows are quarter-end holding context only and do not establish an exact entry date.

Free access includes current parsed ownership filings, reported share changes, and ownership-percentage changes. Filing-specific significance scoring, disclosure-speed analysis, confirmation/divergence signals, and signal alerts require Investor or Pro. The overall institutional consensus preview remains public. Compare plans.

Cross-institution intelligence

Institutional Research

Each institution is compared with its own prior filing, then the latest institution-level directions are compared for breadth.

Latest filing Feb 5, 2026

Public consensus preview Mixed positioning 50/100 institutional research score

2 tracked institutions Latest filing Feb 5, 2026

No institution has two comparable Schedule 13 observations yet.

Accumulating0

Unchanged0

Reducing0

Exited0

The overall consensus is public. Detailed holder comparisons, breadth history, ownership charts, and filing-specific signal analysis remain part of Investor and Pro research.

Price context

52-week position is market context and does not change the institutional consensus score.

52-week low$1.05 52-week high$6.02

Latest close $6.34 100.0% through the range

Tracked institutions

Public holder names and filing freshness. Detailed institution-by-institution analysis is locked.

Latest observation Dec 31, 2025

Fidelity / FMR Feb 5, 2026 filed

BlackRock Jan 21, 2026 filed

Detailed institutional research

See what is driving the consensus.

Unlock holder-by-holder changes, ownership history, breadth by period, disclosure timing, and filing-specific signal analysis.

Create free account Compare Investor and Pro

A free account adds watchlists and reveals tracker research gauges. Investor or Pro unlocks the detailed research above.

Beneficial ownership filing history

Showing 3 of 3 parsed filing(s)

Holder	Observed / filed	Reported change	Shares	Ownership	Observation	Filing	Latest
Fidelity / FMR CIK0000315066	Dec 31, 2025 observed Feb 5, 2026 filed · 36d Schedule 13G amendment	Earliest Schedule 13G amendment found	13.5K	12.00%	$5.50	$4.41	$6.34
BlackRock CIK0002012383	Dec 31, 2025 observed Jan 21, 2026 filed · 21d Schedule 13G amendment	Earliest Schedule 13G amendment found	17.9M	12.00%	$5.50	$4.78	$6.34
BlackRock CIK0002012383	Sep 30, 2024 quarter end Nov 13, 2024 filed Form 13F quarter-end evidence	Earlier Form 13F quarter-end holding Quarter-end holding evidence; no ownership percentage or signal.	13.5M				$6.34

Explore more institutional activity

Related research

Crawlable links to other securities with similar institutional consensus or recent multi-institution accumulation.

Similar research strength

TTAN SERVICETITAN INC-A 50/100 Mixed positioning SITC SITE CENTERS CORP 50/100 Mixed positioning SYNA SYNAPTICS Inc 50/100 Mixed positioning TRU TRANSUNION 50/100 Mixed positioning

Recent multi-institution accumulation

TVTX Travere Therapeutics, Inc. 2 accumulating Aug 6, 2026 PCVX VAXCYTE INC 2 accumulating Aug 6, 2026 VVX V2X INC 2 accumulating Aug 6, 2026 VSEC VSE CORP 3 accumulating Jul 31, 2026